News

The Premier county had a 2024 to forget but will face the losers of the Joe McDonagh Cup final for a place in an All-Ireland ...
TEV-53408 is currently being evaluated in a Phase 2a trial to assess the efficacy and safety in adults with celiac disease. Fast Track is an FDA process designed to facilitate development and ...
"Everywhere I go, every restaurant I go into," he says. Bob has Celiac disease, an autoimmune disease triggered by gluten, a protein found in wheat, barley, and rye. So when the gluten-intolerant ...
Results from a phase 1 study showed TEV-53408 reduced free serum IL-15 levels in healthy participants. The Food and Drug Administration (FDA) has granted Fast Track designation to TEV-53408, an ...
A celiac disease diagnosis can feel daunting and confusing as you learn to navigate the condition. Nutrition experts weigh in on the seven things you should do first once you’ve been diagnosed.
Get Instant Summarized Text (Gist) Persistent symptoms in some celiac patients despite a gluten-free diet are linked to gut immune cells with genetic mutations, which drive ongoing inflammation ...
Fast Track designation granted for investigational TEV-53408, an anti-IL-15 antibody Designation underscores the potential of TEV-53408, currently undergoing a Phase 2a study for the treatment of ...
In celiac disease, the consumption of gluten, which is found in wheat, rye, barley, and some other grains and food products, causes the immune system to erroneously attack the intestine. This leads to ...
ELLINGTON, Conn. (WWLP) – May is Celiac Disease Awareness Month. Some local businesses offer gluten-free goods and no cross-contamination, which allows those with the autoimmune disorder to eat ...
Researchers have discovered why some people with Celiac disease continue to suffer debilitating symptoms despite strictly avoiding gluten. 'Rogue' immune cells explain why a gluten-free diet fails ...
Scientists have identified mutated immune cell clones that could point to improved treatment for refractory celiac disease. Researchers at the Garvan Institute of Medical Research and UNSW Sydney ...